BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.

Autor: Ferreira AK; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands. Electronic address: ferreira-kleber@usp.br., Pasqualoto KF; Biochemistry and Biophysics Laboratory, Butantan Institute, São Paulo, SP, Brazil., Kruyt FA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands., Palace-Berl F; Laboratory of Drug Design and Development, University of São Paulo, São Paulo, SP, Brazil., Azevedo RA; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil., Turra KM; Laboratory of Cytopathology, Department of Clinical Chemistry and Toxicology, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Rodrigues CP; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil., Ferreira AC; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil., Salomón MA; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil., de Sá Junior PL; Laboratory of Genetics, Butantan Institute, São Paulo, SP, Brazil., Farias CF; Experimental Oncology Section, The Federal University of São Paulo, São Paulo, SP, Brazil., Figueiredo CR; Experimental Oncology Section, The Federal University of São Paulo, São Paulo, SP, Brazil., Tavares LC; Laboratory of Drug Design and Development, University of São Paulo, São Paulo, SP, Brazil., Barbuto JA; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil; Cell and Molecular Therapy Center NUCEL-NETCEM, University of São Paulo, SP, Brazil., Jorge SD; Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil. Electronic address: sdjorge@usp.br.

Publikováno v: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2016 Mar 15; Vol. 295, pp. 56-67. Date of Electronic Publication: 2016 Feb 10.

Gefitinib inhibits malignant melanoma cells through the VEGF/AKT signaling pathway.

Autor: Wan, XuefENg¹, Zhu, Yalin¹ yalinzhu123@sina.com, Zhang, Lijuan¹, Hou, Wei¹

Publikováno v: Molecular Medicine Reports. May2018, Vol. 17 Issue 5, p7351-7355. 5p. 2 Black and White Photographs, 1 Chart, 7 Graphs.

Ligand-based design of anticancer MMP2 inhibitors: a review.

Autor: Sanyal, Saptarshi, Amin, Sk Abdul, Adhikari, Nilanjan, Jha, Tarun

Publikováno v: Future Medicinal Chemistry; Nov2021, Vol. 13 Issue 22, p1987-2013, 27p

Goldfrank's Toxicologic Emergencies, Eleventh Edition

Autor: Lewis S. Nelson, Robert S. Hoffman, Mary Ann Howland, Neal A. Lewin, Lewis R. Goldfrank

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. Goldfrank's is the premier toxicology textbook that should be